Key result
Electronegative H5 links to Lp(a), while L5 is elevated in ~5% with LDL-C </dL.
Why the study?
ASCVD risk often persists despite achieving target levels on standard lipid panels, and whether electronegative HDL (H5) and LDL (L5) subfractions provide risk information distinct from standard lipid profiles and Lp(a) needed investigation.
Does quantifying electronegative lipoprotein subfractions H5% and L5% provide cardiovascular risk information distinct from standard lipid panels and Lp(a) in clinical cohorts?
Cross-Sectional (n=1,345)
Does quantifying electronegative lipoprotein subfractions H5% and L5% provide cardiovascular risk information distinct from standard lipid panels and Lp(a) in clinical cohorts?
Answers are grounded in this paper and cite their sources.
Electronegative lipoprotein subfractions H5 and L5 can be pathologically elevated even in patients with optimal standard HDL-C and LDL-C levels, potentially identifying hidden residual ASCVD risk.
Background Atherosclerotic cardiovascular disease (ASCVD) risk often persists despite achieving target levels in standard lipid panels. Qualitative modifications of lipoproteins, specifically the highly atherogenic and pro-inflammatory electronegative subfractions of HDL (H5) and LDL (L5), may drive this residual risk. This study investigates the correlation between these subfractions and quantitative lipid profiles, including total cholesterol (TC), LDL-C, HDL-C, triglycerides (TG), and lipoprotein(a) [Lp(a)]. Purpose To determine whether electronegative subfractions H5% and L5% provide risk information distinct from standard lipid panels and Lp(a) in large clinical cohorts. Methods A large-scale cross-sectional analysis was performed (n=979 for H5; n=1345 for L5). H5% and L5% were isolated and quantified using ion-exchange chromatography. Pearson correlation (r) evaluated the relationships between subfraction proportions and serum lipid levels. Abnormal clinical thresholds were defined for standard lipids (TC > 200, LDL > 130, HDL < 50, TG > 250, Lp(a) > 30 mg/dL) and electronegative subfractions (H5 > 4%, L5 > 2%). Results H5 Subfraction (n=979): H5% demonstrated a strong positive correlation with Lp(a) (r=0.4778, p<0.001), with 8.17% of subjects showing dual elevation. In contrast, H5% showed no significant correlation with standard lipid markers: TC (r=0.0290), HDL-C (r=-0.0306), or TG (r=-0.0266). Notably, 5.82% of patients had pathologically high H5% despite having protective HDL-C levels (> 50 mg/dL). L5 Subfraction (n=1345): L5% showed a highly significant negative correlation with both total LDL-C (r=-0.3643, p<0.001) and TC (r=-0.3513, p<0.001), and a mild positive correlation with TG (r=0.1449, p<0.001). Importantly, a critical subset of patients harbored high atherogenic L5% despite maintaining optimal target levels of LDL-C < 130 mg/dL (5.35%) and TC < 200 mg/dL (4.31%). Conclusions Standard quantitative lipid panels fail to capture the entire spectrum of ASCVD risk. The distinct correlation of H5 with Lp(a) points to a synergistic, non-traditional atherogenic pathway. Furthermore, the inverse relationship between L5 and LDL-C/TC highlights that low cholesterol quantity does not guarantee benign cholesterol quality. Incorporating H5 and L5 testing into clinical practice could critically identify patients with hidden residual risk.Lipid Panel vs L5Lipid Panel vs H5
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2026) conducted a cross-sectional in Atherosclerotic cardiovascular disease (ASCVD) risk / dyslipidemia (n=1,345). Electronegative lipoprotein subfractions H5% and L5% vs. Standard lipid panel (TC, LDL-C, HDL-C, TG) and Lp(a) was evaluated on Correlation between electronegative subfractions (H5%, L5%) and serum lipid levels / Lp(a) (r=0.4778 (H5 vs Lp(a)); r=-0.3643 (L5 vs LDL-C), p=<0.001). Electronegative H5% correlated positively with Lp(a), while L5% correlated inversely with LDL-C and was elevated in 5.35% with LDL-C </dL.
Synapse has enriched 10 related papers. Consider them for comparative context: